-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Differential diagnosis : T1 hyperintensity liver disease
Differential diagnosis : T1 high signal liver disease diagnosis
Differential Diagnosis: T1 Bright Liver Lesions Differential Diagnosis: T1 Bright Liver Lesions
①
① ①
T1 high signal with black ring, T1 high signal with black ring, no enhancement
T1 high signal with black ring, T1 high signal with black ring, no enhancement-
T1 bright with a dark rim
-
T2 bright with a dark rim
-
No enhancement
-
No enhancement
T1 bright with a dark rim
T1 bright with a dark rim
T1 bright with a dark rimT2 bright with a dark rim
T2 bright with a dark rim
T2 bright with a dark rimNo enhancement
No enhancement
No enhancementNo enhancement
No enhancement
No enhancement
Postoperative hematoma
Postoperative hematomahematomaHematoma after surgery
Hematoma after surgery Hematoma after surgery
②
② ②
T1 high signal and low signal focus, T2 low signal and good signal focus, heterogeneous enhancement of the focus, clear solid part
T1 high signal and low signal focus, T2 low signal and good signal focus, heterogeneous enhancement of the focus, clear solid part-
T1 very bright within a dark lesion
-
T2 dark with a bright lesion
-
Heterogeneous enhancement within the lesion
-
Washout within the solid lesion
T1 very bright within a dark lesion
T1 very bright within a dark lesion
T1 very bright within a dark lesionT2 dark with a bright lesion
T2 dark with a bright lesion
T2 dark with a bright lesionHeterogeneous enhancement within the lesion
Heterogeneous enhancement within the lesion
Heterogeneous enhancement within the lesionWashout within the solid lesion
Washout within the solid lesion
Washout within the solid lesion
Carcinoid liver metastases with bleeding
Carcinoid liver metastases with bleeding Carcinoid liver metastases with bleedingHemorrhagic carcinoid metastasis
Hemorrhagic carcinoid metastasis Hemorrhagic carcinoid metastasis
③
③ ③
T1 high signal and low signal focus, T2 mixed signal, irregular ring enhancement, heterogeneous, continuous enhancement
T1 high signal and low signal focus, T2 mixed signal, irregular ring enhancement, heterogeneous, continuous enhancement-
T1 bright and dark lesions
-
T2 mixed signal intensity
-
Irregular ring-shaped enhancement
-
Heterogeneous and persistent enhancement
T1 bright and dark lesions
T1 bright and dark lesions
T1 bright and dark lesionsT2 mixed signal intensity
T2 mixed signal intensity
T2 mixed signal intensityIrregular ring-shaped enhancement
Irregular ring-shaped enhancement
Irregular ring-shaped enhancementHeterogeneous and persistent enhancement
Heterogeneous and persistent enhancement
Heterogeneous and persistent enhancement
Carcinoid liver metastases and protein production
Carcinoid liver metastases and protein production
Protein-producing carcinoid metastasis Protein-producing carcinoid metastasis
④
④ ④
T1 is mainly high signal, T2 waits to bright high signal, T1 high signal part is strengthened, heterogeneity continues to strengthen
T1 is mainly high signal, T2 waits to bright high signal, T1 high signal part is strengthened, heterogeneity continues to strengthen-
T1 (predominantly) bright lesions
-
T2 isointense to very bright
-
Enhancement of the T1-bright parts
-
Heterogeneous and persistent enhancement
T1 (predominantly) bright lesions
T1 (predominantly) bright lesions
T1 (predominantly) bright lesionsT2 isointense to very bright
T2 isointense to very bright
T2 isointense to very brightEnhancement of the T1-bright parts
Enhancement of the T1-bright parts
Enhancement of the T1-bright partsHeterogeneous and persistent enhancement
Heterogeneous and persistent enhancement
Heterogeneous and persistent enhancement
Melanoma liver metastasis
Melanoma liver metastases Melanoma liver metastasesMelanoma metastases
Melanoma metastases Melanoma metastases
summary
Summary summary-
Evaluation T1WI: All lesions have high signal components in the non-cirrhotic liver
-
Evaluation on T2WI: In the first case, the lesion was surrounded by a low-signal edge with increased thickness
-
Assessing the enhanced arterial phase: the first case did not have any enhancement, the second case showed uneven enhancement, and the solid part around the lesion was thicker in the third and fourth cases with enhancement
-
Assess the delayed enhancement period: the first case showed no enhancement, the second case was clear with continuous uneven enhancement, and the third and fourth cases continued to have uneven enhancement at the edge of the lesion
Evaluation T1WI: All lesions have high signal components in the non-cirrhotic liver
Evaluation T1WI: All lesions have high signal components in the non-cirrhotic liver
Evaluation T1WI: All lesions have high signal components in the non-cirrhotic liver
Evaluation on T2WI: In the first case, the lesion was surrounded by a low-signal edge with increased thickness
Evaluation on T2WI: In the first case, the lesion was surrounded by a low-signal edge with increased thickness
Assessing the enhanced arterial phase: the first case did not have any enhancement, the second case showed uneven enhancement, and the solid part around the lesion was thicker in the third and fourth cases with enhancement
Assessing the enhanced arterial phase: the first case did not have any enhancement, the second case showed uneven enhancement, and the solid part around the lesion was thicker in the third and fourth cases with enhancement
Assess the delayed enhancement period: the first case showed no enhancement, the second case was clear with continuous uneven enhancement, and the third and fourth cases continued to have uneven enhancement at the edge of the lesion
Assess the delayed enhancement period: the first case showed no enhancement, the second case was clear with continuous uneven enhancement, and the third and fourth cases continued to have uneven enhancement at the edge of the lesion
.
-
Hematoma: T1 high signal is due to methaemoglobin, and there is a hemosiderin ring at the edge;
-
Hemorrhagic carcinoid metastasis, protein-producing carcinoid metastasis: suggesting metastasis; no specific manifestations; combined with clinical
. -
Melanoma metastasis: combined with medical history, T1 high signal; typical arterial phase is obviously enhanced
.
Hematoma: T1 high signal is due to methaemoglobin, and there is a hemosiderin ring at the edge;
Hematoma: T1 high signal is due to methaemoglobin, and there is a hemosiderin ring at the edge;
Hematoma: T1 high signal is due to methaemoglobin, and there is a hemosiderin ring at the edge;Hemorrhagic carcinoid metastasis, protein-producing carcinoid metastasis: suggesting metastasis; no specific manifestations; combined with clinical
.
Hemorrhagic carcinoid metastasis, protein-producing carcinoid metastasis: suggesting metastasis; no specific manifestations; combined with clinical
.
.
Melanoma metastasis: combined with medical history, T1 high signal; typical arterial phase is obviously enhanced
.
Melanoma metastasis: combined with medical history, T1 high signal; typical arterial phase is obviously enhanced
.
.
In addition, hepatocellular adenomas are prone to hemorrhage, and can also be manifested as T1 hyperintensity, clear borders, obvious enhancement in the arterial phase, iso-signal in the delayed phase, and surrounding pseudo-capsules
.
When combined with massive bleeding, the residual solid part is strengthened
.
.
When combined with massive bleeding, the residual solid part is strengthened
.
☆ Content source: English book "Liver MRI" ☆ Content source: English book "Liver MRI"
Leave a message here